nodes	percent_of_prediction	percent_of_DWPC	metapath
Foscarnet—SLC16A1—Pyruvate metabolism—PDHB—kidney cancer	0.0114	0.128	CbGpPWpGaD
Foscarnet—SLC16A1—Basigin interactions—L1CAM—kidney cancer	0.00896	0.101	CbGpPWpGaD
Foscarnet—SLC16A1—Pyruvate metabolism—LDHB—kidney cancer	0.00688	0.0777	CbGpPWpGaD
Foscarnet—SLC16A1—Pyruvate metabolism and Citric Acid (TCA) cycle—PDHB—kidney cancer	0.00687	0.0776	CbGpPWpGaD
Foscarnet—SLC16A1—Pyruvate metabolism and Citric Acid (TCA) cycle—FH—kidney cancer	0.00521	0.0588	CbGpPWpGaD
Foscarnet—SLC16A1—Pyruvate metabolism—CRABP1—kidney cancer	0.00507	0.0573	CbGpPWpGaD
Foscarnet—SLC16A1—Pyruvate metabolism and Citric Acid (TCA) cycle—LDHB—kidney cancer	0.00416	0.047	CbGpPWpGaD
Foscarnet—SLC16A1—Pyruvate metabolism and Citric Acid (TCA) cycle—CRABP1—kidney cancer	0.00307	0.0347	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—L1CAM—kidney cancer	0.00298	0.0337	CbGpPWpGaD
Foscarnet—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—PDHB—kidney cancer	0.00267	0.0301	CbGpPWpGaD
Foscarnet—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—kidney cancer	0.0023	0.0259	CbGpPWpGaD
Foscarnet—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—FH—kidney cancer	0.00202	0.0228	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—GRB7—kidney cancer	0.00163	0.0184	CbGpPWpGaD
Foscarnet—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—LDHB—kidney cancer	0.00161	0.0182	CbGpPWpGaD
Foscarnet—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—kidney cancer	0.00149	0.0168	CbGpPWpGaD
Foscarnet—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—CRABP1—kidney cancer	0.00119	0.0134	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.00104	0.0118	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000923	0.0104	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—L1CAM—kidney cancer	0.000808	0.00913	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.000677	0.00765	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—ANXA2—kidney cancer	0.000613	0.00692	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000599	0.00677	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.00055	0.00621	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.000532	0.006	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.00053	0.00599	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.00053	0.00599	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.00053	0.00599	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—KCNMA1—kidney cancer	0.000508	0.00573	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ACY1—kidney cancer	0.000473	0.00534	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—GRB7—kidney cancer	0.000443	0.005	CbGpPWpGaD
Foscarnet—Renal impairment—Doxorubicin—kidney cancer	0.000438	0.00048	CcSEcCtD
Foscarnet—Paraesthesia—Vincristine—kidney cancer	0.000437	0.00048	CcSEcCtD
Foscarnet—Dermatitis bullous—Doxorubicin—kidney cancer	0.000436	0.000478	CcSEcCtD
Foscarnet—Agitation—Paclitaxel—kidney cancer	0.000436	0.000478	CcSEcCtD
Foscarnet—Rash—Everolimus—kidney cancer	0.000435	0.000477	CcSEcCtD
Foscarnet—Dermatitis—Everolimus—kidney cancer	0.000434	0.000476	CcSEcCtD
Foscarnet—Headache—Vinblastine—kidney cancer	0.000434	0.000476	CcSEcCtD
Foscarnet—Headache—Everolimus—kidney cancer	0.000432	0.000474	CcSEcCtD
Foscarnet—Hypotension—Gemcitabine—kidney cancer	0.000432	0.000474	CcSEcCtD
Foscarnet—Body temperature increased—Dactinomycin—kidney cancer	0.000431	0.000473	CcSEcCtD
Foscarnet—Abdominal pain—Dactinomycin—kidney cancer	0.000431	0.000473	CcSEcCtD
Foscarnet—Asthenia—Sorafenib—kidney cancer	0.000429	0.000471	CcSEcCtD
Foscarnet—Malaise—Paclitaxel—kidney cancer	0.000427	0.000469	CcSEcCtD
Foscarnet—Leukopenia—Paclitaxel—kidney cancer	0.000424	0.000466	CcSEcCtD
Foscarnet—Decreased appetite—Vincristine—kidney cancer	0.000423	0.000465	CcSEcCtD
Foscarnet—Pruritus—Sorafenib—kidney cancer	0.000423	0.000465	CcSEcCtD
Foscarnet—Vomiting—Erlotinib—kidney cancer	0.000423	0.000464	CcSEcCtD
Foscarnet—Erythema multiforme—Capecitabine—kidney cancer	0.000423	0.000464	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000421	0.000462	CcSEcCtD
Foscarnet—Fatigue—Vincristine—kidney cancer	0.00042	0.000461	CcSEcCtD
Foscarnet—Rash—Erlotinib—kidney cancer	0.000419	0.00046	CcSEcCtD
Foscarnet—Dermatitis—Erlotinib—kidney cancer	0.000419	0.00046	CcSEcCtD
Foscarnet—Palpitations—Paclitaxel—kidney cancer	0.000419	0.00046	CcSEcCtD
Foscarnet—Hyponatraemia—Doxorubicin—kidney cancer	0.000418	0.000459	CcSEcCtD
Foscarnet—Insomnia—Gemcitabine—kidney cancer	0.000418	0.000459	CcSEcCtD
Foscarnet—Eye disorder—Capecitabine—kidney cancer	0.000418	0.000458	CcSEcCtD
Foscarnet—Headache—Erlotinib—kidney cancer	0.000417	0.000457	CcSEcCtD
Foscarnet—Constipation—Vincristine—kidney cancer	0.000417	0.000457	CcSEcCtD
Foscarnet—Pain—Vincristine—kidney cancer	0.000417	0.000457	CcSEcCtD
Foscarnet—Paraesthesia—Gemcitabine—kidney cancer	0.000415	0.000455	CcSEcCtD
Foscarnet—Flushing—Capecitabine—kidney cancer	0.000415	0.000455	CcSEcCtD
Foscarnet—Cough—Paclitaxel—kidney cancer	0.000414	0.000454	CcSEcCtD
Foscarnet—Asthenia—Sunitinib—kidney cancer	0.000413	0.000453	CcSEcCtD
Foscarnet—Dyspnoea—Gemcitabine—kidney cancer	0.000412	0.000452	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—ITPR2—kidney cancer	0.000412	0.00465	CbGpPWpGaD
Foscarnet—Nausea—Vinblastine—kidney cancer	0.000411	0.000451	CcSEcCtD
Foscarnet—Somnolence—Gemcitabine—kidney cancer	0.000411	0.000451	CcSEcCtD
Foscarnet—Convulsion—Paclitaxel—kidney cancer	0.000411	0.000451	CcSEcCtD
Foscarnet—Nausea—Everolimus—kidney cancer	0.00041	0.000449	CcSEcCtD
Foscarnet—Diarrhoea—Sorafenib—kidney cancer	0.000409	0.000449	CcSEcCtD
Foscarnet—Hypertension—Paclitaxel—kidney cancer	0.000409	0.000449	CcSEcCtD
Foscarnet—Pruritus—Sunitinib—kidney cancer	0.000407	0.000447	CcSEcCtD
Foscarnet—Chest pain—Paclitaxel—kidney cancer	0.000404	0.000443	CcSEcCtD
Foscarnet—Arthralgia—Paclitaxel—kidney cancer	0.000404	0.000443	CcSEcCtD
Foscarnet—Myalgia—Paclitaxel—kidney cancer	0.000404	0.000443	CcSEcCtD
Foscarnet—Anxiety—Paclitaxel—kidney cancer	0.000402	0.000441	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—PDHB—kidney cancer	0.000402	0.00454	CbGpPWpGaD
Foscarnet—Face oedema—Doxorubicin—kidney cancer	0.000402	0.000441	CcSEcCtD
Foscarnet—Decreased appetite—Gemcitabine—kidney cancer	0.000402	0.000441	CcSEcCtD
Foscarnet—Chills—Capecitabine—kidney cancer	0.000401	0.00044	CcSEcCtD
Foscarnet—Discomfort—Paclitaxel—kidney cancer	0.000399	0.000437	CcSEcCtD
Foscarnet—Fatigue—Gemcitabine—kidney cancer	0.000398	0.000437	CcSEcCtD
Foscarnet—Gastrointestinal pain—Vincristine—kidney cancer	0.000398	0.000437	CcSEcCtD
Foscarnet—Cardiac arrest—Doxorubicin—kidney cancer	0.000396	0.000434	CcSEcCtD
Foscarnet—Dizziness—Sorafenib—kidney cancer	0.000396	0.000434	CcSEcCtD
Foscarnet—Pain—Gemcitabine—kidney cancer	0.000395	0.000434	CcSEcCtD
Foscarnet—Constipation—Gemcitabine—kidney cancer	0.000395	0.000434	CcSEcCtD
Foscarnet—Nausea—Erlotinib—kidney cancer	0.000395	0.000434	CcSEcCtD
Foscarnet—Dry mouth—Paclitaxel—kidney cancer	0.000395	0.000433	CcSEcCtD
Foscarnet—Diarrhoea—Sunitinib—kidney cancer	0.000394	0.000432	CcSEcCtD
Foscarnet—Ataxia—Doxorubicin—kidney cancer	0.000392	0.00043	CcSEcCtD
Foscarnet—Asthenia—Dactinomycin—kidney cancer	0.000391	0.000429	CcSEcCtD
Foscarnet—Confusional state—Paclitaxel—kidney cancer	0.00039	0.000428	CcSEcCtD
Foscarnet—Blood creatinine increased—Doxorubicin—kidney cancer	0.00039	0.000428	CcSEcCtD
Foscarnet—Dehydration—Doxorubicin—kidney cancer	0.000387	0.000425	CcSEcCtD
Foscarnet—Oedema—Paclitaxel—kidney cancer	0.000387	0.000424	CcSEcCtD
Foscarnet—Body temperature increased—Vincristine—kidney cancer	0.000385	0.000422	CcSEcCtD
Foscarnet—Abdominal pain—Vincristine—kidney cancer	0.000385	0.000422	CcSEcCtD
Foscarnet—Infection—Paclitaxel—kidney cancer	0.000384	0.000422	CcSEcCtD
Foscarnet—Flatulence—Capecitabine—kidney cancer	0.000383	0.000421	CcSEcCtD
Foscarnet—Dizziness—Sunitinib—kidney cancer	0.000381	0.000418	CcSEcCtD
Foscarnet—Feeling abnormal—Gemcitabine—kidney cancer	0.000381	0.000418	CcSEcCtD
Foscarnet—Vomiting—Sorafenib—kidney cancer	0.000381	0.000417	CcSEcCtD
Foscarnet—Hypokalaemia—Doxorubicin—kidney cancer	0.000379	0.000416	CcSEcCtD
Foscarnet—Thrombocytopenia—Paclitaxel—kidney cancer	0.000379	0.000416	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—CCBL1—kidney cancer	0.000378	0.00427	CbGpPWpGaD
Foscarnet—Rash—Sorafenib—kidney cancer	0.000377	0.000414	CcSEcCtD
Foscarnet—Dermatitis—Sorafenib—kidney cancer	0.000377	0.000414	CcSEcCtD
Foscarnet—Back pain—Capecitabine—kidney cancer	0.000376	0.000413	CcSEcCtD
Foscarnet—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.000375	0.000411	CcSEcCtD
Foscarnet—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000375	0.000411	CcSEcCtD
Foscarnet—Headache—Sorafenib—kidney cancer	0.000375	0.000411	CcSEcCtD
Foscarnet—Muscle spasms—Capecitabine—kidney cancer	0.000374	0.00041	CcSEcCtD
Foscarnet—Hyperhidrosis—Paclitaxel—kidney cancer	0.000374	0.00041	CcSEcCtD
Foscarnet—Diarrhoea—Dactinomycin—kidney cancer	0.000373	0.000409	CcSEcCtD
Foscarnet—Anorexia—Paclitaxel—kidney cancer	0.000369	0.000405	CcSEcCtD
Foscarnet—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000367	0.000403	CcSEcCtD
Foscarnet—Muscular weakness—Doxorubicin—kidney cancer	0.000367	0.000403	CcSEcCtD
Foscarnet—Vomiting—Sunitinib—kidney cancer	0.000366	0.000402	CcSEcCtD
Foscarnet—Body temperature increased—Gemcitabine—kidney cancer	0.000365	0.000401	CcSEcCtD
Foscarnet—Tremor—Capecitabine—kidney cancer	0.000364	0.0004	CcSEcCtD
Foscarnet—Rash—Sunitinib—kidney cancer	0.000363	0.000398	CcSEcCtD
Foscarnet—Dermatitis—Sunitinib—kidney cancer	0.000363	0.000398	CcSEcCtD
Foscarnet—Hypotension—Paclitaxel—kidney cancer	0.000361	0.000397	CcSEcCtD
Foscarnet—Ill-defined disorder—Capecitabine—kidney cancer	0.000361	0.000396	CcSEcCtD
Foscarnet—Headache—Sunitinib—kidney cancer	0.000361	0.000396	CcSEcCtD
Foscarnet—Dysphagia—Doxorubicin—kidney cancer	0.00036	0.000395	CcSEcCtD
Foscarnet—Anaemia—Capecitabine—kidney cancer	0.00036	0.000394	CcSEcCtD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.000357	0.00403	CbGpPWpGaD
Foscarnet—Nausea—Sorafenib—kidney cancer	0.000355	0.00039	CcSEcCtD
Foscarnet—Pancreatitis—Doxorubicin—kidney cancer	0.000353	0.000387	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000352	0.000387	CcSEcCtD
Foscarnet—Malaise—Capecitabine—kidney cancer	0.000351	0.000385	CcSEcCtD
Foscarnet—Insomnia—Paclitaxel—kidney cancer	0.00035	0.000384	CcSEcCtD
Foscarnet—Asthenia—Vincristine—kidney cancer	0.000349	0.000383	CcSEcCtD
Foscarnet—Leukopenia—Capecitabine—kidney cancer	0.000348	0.000382	CcSEcCtD
Foscarnet—Paraesthesia—Paclitaxel—kidney cancer	0.000347	0.000381	CcSEcCtD
Foscarnet—Vomiting—Dactinomycin—kidney cancer	0.000347	0.00038	CcSEcCtD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.000345	0.0039	CbGpPWpGaD
Foscarnet—Dyspnoea—Paclitaxel—kidney cancer	0.000345	0.000378	CcSEcCtD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000344	0.00389	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000344	0.00389	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000344	0.00389	CbGpPWpGaD
Foscarnet—Somnolence—Paclitaxel—kidney cancer	0.000344	0.000377	CcSEcCtD
Foscarnet—Palpitations—Capecitabine—kidney cancer	0.000344	0.000377	CcSEcCtD
Foscarnet—Rash—Dactinomycin—kidney cancer	0.000344	0.000377	CcSEcCtD
Foscarnet—Nausea—Sunitinib—kidney cancer	0.000342	0.000375	CcSEcCtD
Foscarnet—Pancytopenia—Doxorubicin—kidney cancer	0.000342	0.000375	CcSEcCtD
Foscarnet—Dyspepsia—Paclitaxel—kidney cancer	0.000341	0.000374	CcSEcCtD
Foscarnet—Cough—Capecitabine—kidney cancer	0.000339	0.000372	CcSEcCtD
Foscarnet—Dysuria—Doxorubicin—kidney cancer	0.000337	0.000369	CcSEcCtD
Foscarnet—Neutropenia—Doxorubicin—kidney cancer	0.000337	0.000369	CcSEcCtD
Foscarnet—Decreased appetite—Paclitaxel—kidney cancer	0.000336	0.000369	CcSEcCtD
Foscarnet—Hypertension—Capecitabine—kidney cancer	0.000336	0.000368	CcSEcCtD
Foscarnet—Fatigue—Paclitaxel—kidney cancer	0.000334	0.000366	CcSEcCtD
Foscarnet—Diarrhoea—Vincristine—kidney cancer	0.000333	0.000366	CcSEcCtD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—KRAS—kidney cancer	0.000333	0.00376	CbGpPWpGaD
Foscarnet—Asthenia—Gemcitabine—kidney cancer	0.000332	0.000364	CcSEcCtD
Foscarnet—Chest pain—Capecitabine—kidney cancer	0.000331	0.000363	CcSEcCtD
Foscarnet—Arthralgia—Capecitabine—kidney cancer	0.000331	0.000363	CcSEcCtD
Foscarnet—Myalgia—Capecitabine—kidney cancer	0.000331	0.000363	CcSEcCtD
Foscarnet—Constipation—Paclitaxel—kidney cancer	0.000331	0.000363	CcSEcCtD
Foscarnet—Pain—Paclitaxel—kidney cancer	0.000331	0.000363	CcSEcCtD
Foscarnet—Anxiety—Capecitabine—kidney cancer	0.00033	0.000362	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—PPAT—kidney cancer	0.000328	0.0037	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GLIPR1—kidney cancer	0.000328	0.0037	CbGpPWpGaD
Foscarnet—Discomfort—Capecitabine—kidney cancer	0.000327	0.000359	CcSEcCtD
Foscarnet—Pruritus—Gemcitabine—kidney cancer	0.000327	0.000359	CcSEcCtD
Foscarnet—Weight decreased—Doxorubicin—kidney cancer	0.000326	0.000357	CcSEcCtD
Foscarnet—Dry mouth—Capecitabine—kidney cancer	0.000324	0.000355	CcSEcCtD
Foscarnet—Nausea—Dactinomycin—kidney cancer	0.000324	0.000355	CcSEcCtD
Foscarnet—Dizziness—Vincristine—kidney cancer	0.000322	0.000353	CcSEcCtD
Foscarnet—Confusional state—Capecitabine—kidney cancer	0.00032	0.000351	CcSEcCtD
Foscarnet—Feeling abnormal—Paclitaxel—kidney cancer	0.000319	0.00035	CcSEcCtD
Foscarnet—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000318	0.000349	CcSEcCtD
Foscarnet—Oedema—Capecitabine—kidney cancer	0.000317	0.000348	CcSEcCtD
Foscarnet—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000316	0.000347	CcSEcCtD
Foscarnet—Diarrhoea—Gemcitabine—kidney cancer	0.000316	0.000347	CcSEcCtD
Foscarnet—Renal failure—Doxorubicin—kidney cancer	0.000315	0.000346	CcSEcCtD
Foscarnet—Infection—Capecitabine—kidney cancer	0.000315	0.000346	CcSEcCtD
Foscarnet—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000315	0.000345	CcSEcCtD
Foscarnet—Conjunctivitis—Doxorubicin—kidney cancer	0.000312	0.000342	CcSEcCtD
Foscarnet—Urinary tract infection—Doxorubicin—kidney cancer	0.000312	0.000342	CcSEcCtD
Foscarnet—Thrombocytopenia—Capecitabine—kidney cancer	0.000311	0.000341	CcSEcCtD
Foscarnet—Vomiting—Vincristine—kidney cancer	0.00031	0.00034	CcSEcCtD
Foscarnet—Rash—Vincristine—kidney cancer	0.000307	0.000337	CcSEcCtD
Foscarnet—Hyperhidrosis—Capecitabine—kidney cancer	0.000307	0.000337	CcSEcCtD
Foscarnet—Dermatitis—Vincristine—kidney cancer	0.000307	0.000337	CcSEcCtD
Foscarnet—Haematuria—Doxorubicin—kidney cancer	0.000306	0.000336	CcSEcCtD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—PIK3CA—kidney cancer	0.000306	0.00345	CbGpPWpGaD
Foscarnet—Abdominal pain—Paclitaxel—kidney cancer	0.000306	0.000336	CcSEcCtD
Foscarnet—Body temperature increased—Paclitaxel—kidney cancer	0.000306	0.000336	CcSEcCtD
Foscarnet—Headache—Vincristine—kidney cancer	0.000305	0.000335	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—FH—kidney cancer	0.000305	0.00344	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—APRT—kidney cancer	0.000305	0.00344	CbGpPWpGaD
Foscarnet—Anorexia—Capecitabine—kidney cancer	0.000303	0.000332	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—IFNA1—kidney cancer	0.000302	0.00341	CbGpPWpGaD
Foscarnet—Sinusitis—Doxorubicin—kidney cancer	0.000301	0.00033	CcSEcCtD
Foscarnet—Agranulocytosis—Doxorubicin—kidney cancer	0.000299	0.000329	CcSEcCtD
Foscarnet—Hypotension—Capecitabine—kidney cancer	0.000297	0.000325	CcSEcCtD
Foscarnet—Vomiting—Gemcitabine—kidney cancer	0.000294	0.000322	CcSEcCtD
Foscarnet—Rash—Gemcitabine—kidney cancer	0.000291	0.00032	CcSEcCtD
Foscarnet—Dermatitis—Gemcitabine—kidney cancer	0.000291	0.000319	CcSEcCtD
Foscarnet—Headache—Gemcitabine—kidney cancer	0.000289	0.000318	CcSEcCtD
Foscarnet—Nausea—Vincristine—kidney cancer	0.000289	0.000317	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000289	0.000317	CcSEcCtD
Foscarnet—Rhinitis—Doxorubicin—kidney cancer	0.000289	0.000317	CcSEcCtD
Foscarnet—Insomnia—Capecitabine—kidney cancer	0.000287	0.000315	CcSEcCtD
Foscarnet—Hypoaesthesia—Doxorubicin—kidney cancer	0.000287	0.000314	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—GPC3—kidney cancer	0.000286	0.00323	CbGpPWpGaD
Foscarnet—Pharyngitis—Doxorubicin—kidney cancer	0.000286	0.000314	CcSEcCtD
Foscarnet—Paraesthesia—Capecitabine—kidney cancer	0.000285	0.000313	CcSEcCtD
Foscarnet—Dyspnoea—Capecitabine—kidney cancer	0.000283	0.000311	CcSEcCtD
Foscarnet—Urethral disorder—Doxorubicin—kidney cancer	0.000282	0.00031	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—IFNA2—kidney cancer	0.000281	0.00318	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.00028	0.00316	CbGpPWpGaD
Foscarnet—Dyspepsia—Capecitabine—kidney cancer	0.000279	0.000307	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—CA2—kidney cancer	0.000279	0.00315	CbGpPWpGaD
Foscarnet—Asthenia—Paclitaxel—kidney cancer	0.000278	0.000305	CcSEcCtD
Foscarnet—Decreased appetite—Capecitabine—kidney cancer	0.000276	0.000303	CcSEcCtD
Foscarnet—Nausea—Gemcitabine—kidney cancer	0.000274	0.000301	CcSEcCtD
Foscarnet—Fatigue—Capecitabine—kidney cancer	0.000274	0.0003	CcSEcCtD
Foscarnet—Pruritus—Paclitaxel—kidney cancer	0.000274	0.0003	CcSEcCtD
Foscarnet—Erythema multiforme—Doxorubicin—kidney cancer	0.000272	0.000299	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—ALAD—kidney cancer	0.000272	0.00307	CbGpPWpGaD
Foscarnet—Pain—Capecitabine—kidney cancer	0.000271	0.000298	CcSEcCtD
Foscarnet—Constipation—Capecitabine—kidney cancer	0.000271	0.000298	CcSEcCtD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.00027	0.00305	CbGpPWpGaD
Foscarnet—Eye disorder—Doxorubicin—kidney cancer	0.000269	0.000295	CcSEcCtD
Foscarnet—Flushing—Doxorubicin—kidney cancer	0.000267	0.000293	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—ST3GAL2—kidney cancer	0.000265	0.00299	CbGpPWpGaD
Foscarnet—Diarrhoea—Paclitaxel—kidney cancer	0.000265	0.00029	CcSEcCtD
Foscarnet—Feeling abnormal—Capecitabine—kidney cancer	0.000262	0.000287	CcSEcCtD
Foscarnet—Gastrointestinal pain—Capecitabine—kidney cancer	0.00026	0.000285	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—ALDH1A1—kidney cancer	0.000259	0.00292	CbGpPWpGaD
Foscarnet—Chills—Doxorubicin—kidney cancer	0.000258	0.000284	CcSEcCtD
Foscarnet—Dizziness—Paclitaxel—kidney cancer	0.000256	0.000281	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—IGF2—kidney cancer	0.000253	0.00286	CbGpPWpGaD
Foscarnet—Abdominal pain—Capecitabine—kidney cancer	0.000251	0.000275	CcSEcCtD
Foscarnet—Body temperature increased—Capecitabine—kidney cancer	0.000251	0.000275	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—SLC5A3—kidney cancer	0.000248	0.0028	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PGK1—kidney cancer	0.000248	0.0028	CbGpPWpGaD
Foscarnet—Flatulence—Doxorubicin—kidney cancer	0.000247	0.000271	CcSEcCtD
Foscarnet—Tension—Doxorubicin—kidney cancer	0.000246	0.00027	CcSEcCtD
Foscarnet—Vomiting—Paclitaxel—kidney cancer	0.000246	0.00027	CcSEcCtD
Foscarnet—Rash—Paclitaxel—kidney cancer	0.000244	0.000268	CcSEcCtD
Foscarnet—Dermatitis—Paclitaxel—kidney cancer	0.000244	0.000267	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—LDHB—kidney cancer	0.000244	0.00275	CbGpPWpGaD
Foscarnet—Nervousness—Doxorubicin—kidney cancer	0.000244	0.000267	CcSEcCtD
Foscarnet—Back pain—Doxorubicin—kidney cancer	0.000243	0.000266	CcSEcCtD
Foscarnet—Headache—Paclitaxel—kidney cancer	0.000242	0.000266	CcSEcCtD
Foscarnet—Muscle spasms—Doxorubicin—kidney cancer	0.000241	0.000265	CcSEcCtD
Foscarnet—Ill-defined disorder—Doxorubicin—kidney cancer	0.000233	0.000255	CcSEcCtD
Foscarnet—Anaemia—Doxorubicin—kidney cancer	0.000232	0.000254	CcSEcCtD
Foscarnet—Agitation—Doxorubicin—kidney cancer	0.00023	0.000253	CcSEcCtD
Foscarnet—Nausea—Paclitaxel—kidney cancer	0.00023	0.000252	CcSEcCtD
Foscarnet—Asthenia—Capecitabine—kidney cancer	0.000228	0.00025	CcSEcCtD
Foscarnet—Malaise—Doxorubicin—kidney cancer	0.000226	0.000248	CcSEcCtD
Foscarnet—Pruritus—Capecitabine—kidney cancer	0.000225	0.000246	CcSEcCtD
Foscarnet—Leukopenia—Doxorubicin—kidney cancer	0.000224	0.000246	CcSEcCtD
Foscarnet—Palpitations—Doxorubicin—kidney cancer	0.000222	0.000243	CcSEcCtD
Foscarnet—Cough—Doxorubicin—kidney cancer	0.000219	0.00024	CcSEcCtD
Foscarnet—Convulsion—Doxorubicin—kidney cancer	0.000217	0.000238	CcSEcCtD
Foscarnet—Diarrhoea—Capecitabine—kidney cancer	0.000217	0.000238	CcSEcCtD
Foscarnet—Hypertension—Doxorubicin—kidney cancer	0.000216	0.000238	CcSEcCtD
Foscarnet—Chest pain—Doxorubicin—kidney cancer	0.000213	0.000234	CcSEcCtD
Foscarnet—Myalgia—Doxorubicin—kidney cancer	0.000213	0.000234	CcSEcCtD
Foscarnet—Arthralgia—Doxorubicin—kidney cancer	0.000213	0.000234	CcSEcCtD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000213	0.00241	CbGpPWpGaD
Foscarnet—Anxiety—Doxorubicin—kidney cancer	0.000213	0.000233	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—CA9—kidney cancer	0.000211	0.00238	CbGpPWpGaD
Foscarnet—Discomfort—Doxorubicin—kidney cancer	0.000211	0.000231	CcSEcCtD
Foscarnet—Dizziness—Capecitabine—kidney cancer	0.00021	0.00023	CcSEcCtD
Foscarnet—Dry mouth—Doxorubicin—kidney cancer	0.000209	0.000229	CcSEcCtD
Foscarnet—Confusional state—Doxorubicin—kidney cancer	0.000206	0.000226	CcSEcCtD
Foscarnet—Oedema—Doxorubicin—kidney cancer	0.000205	0.000225	CcSEcCtD
Foscarnet—Infection—Doxorubicin—kidney cancer	0.000203	0.000223	CcSEcCtD
Foscarnet—Vomiting—Capecitabine—kidney cancer	0.000202	0.000221	CcSEcCtD
Foscarnet—Thrombocytopenia—Doxorubicin—kidney cancer	0.0002	0.00022	CcSEcCtD
Foscarnet—Rash—Capecitabine—kidney cancer	0.0002	0.00022	CcSEcCtD
Foscarnet—Dermatitis—Capecitabine—kidney cancer	0.0002	0.000219	CcSEcCtD
Foscarnet—Headache—Capecitabine—kidney cancer	0.000199	0.000218	CcSEcCtD
Foscarnet—Hyperhidrosis—Doxorubicin—kidney cancer	0.000198	0.000217	CcSEcCtD
Foscarnet—Anorexia—Doxorubicin—kidney cancer	0.000195	0.000214	CcSEcCtD
Foscarnet—Hypotension—Doxorubicin—kidney cancer	0.000191	0.00021	CcSEcCtD
Foscarnet—Nausea—Capecitabine—kidney cancer	0.000189	0.000207	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000186	0.000205	CcSEcCtD
Foscarnet—Insomnia—Doxorubicin—kidney cancer	0.000185	0.000203	CcSEcCtD
Foscarnet—Paraesthesia—Doxorubicin—kidney cancer	0.000184	0.000202	CcSEcCtD
Foscarnet—Dyspnoea—Doxorubicin—kidney cancer	0.000182	0.0002	CcSEcCtD
Foscarnet—Somnolence—Doxorubicin—kidney cancer	0.000182	0.0002	CcSEcCtD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000182	0.00205	CbGpPWpGaD
Foscarnet—Dyspepsia—Doxorubicin—kidney cancer	0.00018	0.000198	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—CRABP1—kidney cancer	0.00018	0.00203	CbGpPWpGaD
Foscarnet—Decreased appetite—Doxorubicin—kidney cancer	0.000178	0.000195	CcSEcCtD
Foscarnet—Fatigue—Doxorubicin—kidney cancer	0.000176	0.000194	CcSEcCtD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000175	0.00198	CbGpPWpGaD
Foscarnet—Pain—Doxorubicin—kidney cancer	0.000175	0.000192	CcSEcCtD
Foscarnet—Constipation—Doxorubicin—kidney cancer	0.000175	0.000192	CcSEcCtD
Foscarnet—Feeling abnormal—Doxorubicin—kidney cancer	0.000169	0.000185	CcSEcCtD
Foscarnet—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000167	0.000184	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—ITPR2—kidney cancer	0.000167	0.00188	CbGpPWpGaD
Foscarnet—Body temperature increased—Doxorubicin—kidney cancer	0.000162	0.000177	CcSEcCtD
Foscarnet—Abdominal pain—Doxorubicin—kidney cancer	0.000162	0.000177	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—ACHE—kidney cancer	0.000152	0.00172	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GSTT1—kidney cancer	0.000152	0.00172	CbGpPWpGaD
Foscarnet—Asthenia—Doxorubicin—kidney cancer	0.000147	0.000161	CcSEcCtD
Foscarnet—Pruritus—Doxorubicin—kidney cancer	0.000145	0.000159	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—SCARB1—kidney cancer	0.000144	0.00163	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PTGS1—kidney cancer	0.000143	0.00161	CbGpPWpGaD
Foscarnet—Diarrhoea—Doxorubicin—kidney cancer	0.00014	0.000154	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—PSMD7—kidney cancer	0.00014	0.00158	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—RAF1—kidney cancer	0.000139	0.00157	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000138	0.00156	CbGpPWpGaD
Foscarnet—Dizziness—Doxorubicin—kidney cancer	0.000135	0.000148	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—BCHE—kidney cancer	0.000133	0.0015	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—SLC5A5—kidney cancer	0.000131	0.00148	CbGpPWpGaD
Foscarnet—Vomiting—Doxorubicin—kidney cancer	0.00013	0.000143	CcSEcCtD
Foscarnet—Rash—Doxorubicin—kidney cancer	0.000129	0.000142	CcSEcCtD
Foscarnet—Dermatitis—Doxorubicin—kidney cancer	0.000129	0.000141	CcSEcCtD
Foscarnet—Headache—Doxorubicin—kidney cancer	0.000128	0.000141	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—SLC2A1—kidney cancer	0.000127	0.00143	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—IL2—kidney cancer	0.000125	0.00141	CbGpPWpGaD
Foscarnet—Nausea—Doxorubicin—kidney cancer	0.000122	0.000133	CcSEcCtD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000121	0.00136	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—VEGFA—kidney cancer	0.000106	0.0012	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GSTP1—kidney cancer	0.000106	0.00119	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—MAPK3—kidney cancer	0.0001	0.00113	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ABCB1—kidney cancer	9.99e-05	0.00113	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GSTM1—kidney cancer	9.7e-05	0.00109	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—MAPK1—kidney cancer	9.56e-05	0.00108	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CYP1A1—kidney cancer	9.19e-05	0.00104	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—KRAS—kidney cancer	9.03e-05	0.00102	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—PIK3CA—kidney cancer	8.29e-05	0.000936	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—TP53—kidney cancer	8.02e-05	0.000906	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—RAF1—kidney cancer	7.83e-05	0.000884	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—POMC—kidney cancer	6.85e-05	0.000774	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PTGS2—kidney cancer	5.47e-05	0.000617	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PTEN—kidney cancer	4.77e-05	0.000538	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PIK3CA—kidney cancer	3.36e-05	0.00038	CbGpPWpGaD
